[{"address1": "828 Winter Street", "address2": "Suite 300", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857-524-2466", "website": "https://xiliotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 64, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rene  Russo BCPS, Pharm.D.", "age": 49, "title": "President, CEO & Director", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 966228, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Frankenfield", "age": 42, "title": "CFO & COO", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 786196, "exercisedValue": 0, "unexercisedValue": 260}, {"maxAge": 1, "name": "Dr. Katarina  Luptakova M.D.", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 661890, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin M. Brennan", "age": 54, "title": "Senior Vice President of Finance & Accounting", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Uli  Bialucha Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caroline  Hensley", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott  Coleman Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.897, "open": 0.897, "dayLow": 0.861, "dayHigh": 0.9, "regularMarketPreviousClose": 0.897, "regularMarketOpen": 0.897, "regularMarketDayLow": 0.861, "regularMarketDayHigh": 0.9, "payoutRatio": 0.0, "beta": -0.233, "forwardPE": -1.5237932, "volume": 231234, "regularMarketVolume": 231234, "averageVolume": 1137517, "averageVolume10days": 5286370, "averageDailyVolume10Day": 5286370, "bid": 0.8519, "ask": 0.9015, "bidSize": 4, "askSize": 1, "marketCap": 45765200, "fiftyTwoWeekLow": 0.62, "fiftyTwoWeekHigh": 1.7, "priceToSalesTrailing12Months": 4.9347854, "fiftyDayAverage": 0.77076, "twoHundredDayAverage": 0.88664, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -35443828, "profitMargins": 0.0, "floatShares": 25003071, "sharesOutstanding": 51782300, "sharesShort": 351157, "sharesShortPriorMonth": 644535, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.0068, "heldPercentInsiders": 0.28177, "heldPercentInstitutions": 0.40575, "shortRatio": 1.73, "shortPercentOfFloat": 0.0099, "impliedSharesOutstanding": 51782300, "bookValue": 0.207, "priceToBook": 4.269565, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -54303000, "trailingEps": -0.65, "forwardEps": -0.58, "enterpriseToRevenue": -3.822, "enterpriseToEbitda": 0.641, "52WeekChange": -0.0359869, "SandP52WeekChange": 0.09362543, "quoteType": "EQUITY", "currentPrice": 0.8838, "recommendationKey": "none", "totalCash": 89073000, "totalCashPerShare": 1.72, "ebitda": -55259000, "totalDebt": 7864000, "quickRatio": 1.912, "currentRatio": 1.956, "totalRevenue": 9274000, "debtToEquity": 73.495, "revenuePerShare": 0.142, "returnOnAssets": -0.38211, "returnOnEquity": -2.97836, "grossProfits": 9274000, "freeCashflow": 19131376, "operatingCashflow": 21102000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -4.7273, "financialCurrency": "USD", "symbol": "XLO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Xilio Therapeutics, Inc.", "longName": "Xilio Therapeutics, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": -1.4715703, "regularMarketPrice": 0.8838, "corporateActions": [], "postMarketTime": 1748041566, "regularMarketTime": 1748030400, "exchange": "NMS", "messageBoardId": "finmb_365333564", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": -1.56144, "postMarketPrice": 0.87, "postMarketChange": -0.0138, "regularMarketChange": -0.013199985, "regularMarketDayRange": "0.861 - 0.9", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1137517, "fiftyTwoWeekLowChange": 0.26380002, "fiftyTwoWeekLowChangePercent": 0.4254839, "fiftyTwoWeekRange": "0.62 - 1.7", "fiftyTwoWeekHighChange": -0.8162, "fiftyTwoWeekHighChangePercent": -0.48011765, "fiftyTwoWeekChangePercent": -3.59869, "earningsTimestamp": 1746703800, "earningsTimestampStart": 1754479858, "earningsTimestampEnd": 1754911858, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.65, "epsForward": -0.58, "fiftyDayAverageChange": 0.11304003, "fiftyDayAverageChangePercent": 0.14666048, "twoHundredDayAverageChange": -0.0028399825, "twoHundredDayAverageChangePercent": -0.003203084, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-22", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634909400000, "displayName": "Xilio Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-24"}]